Back to discover
Drug

Polytetrafluoroethylene

In clinical development
Emerging researchIn clinical testing

Also known as PTFE - Polytetrafluoroethylene, Paratetrafluoroethylene.

RxNorm1358182
1
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Polytetrafluoroethylene
Aliases & brands
PTFE - PolytetrafluoroethyleneParatetrafluoroethylene
RxNorm CUI
1358182

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
1
Late-stage (III+)
1
Discontinued
PHASE DISTRIBUTIONn = 1
Phase N / A1

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Most influential

Influenza virus in human exhaled breath: an observational study.

PloS one · 2008 · 317 cites
Journals, researchers & institutions
Top journals
  • PloS one1
Leading researchers
  • Chan KH1
  • Cowling BJ1
  • DeHaan WH1
  • Fabian P1
  • Fung RO1
  • Leung GM1
  • McDevitt JJ1
  • Milton DK1
Leading institutions
free-text, unnormalised
  • University of Massachusetts Lowell1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials